Chronic Heart Failure
Conditions
Keywords
Chronic heart failure, Nurse, Heart Failure Nurse Specialists, Advanced practice nursing, Treatment titration, Care pathway
Brief summary
The management of chronic heart failure, following current guidelines, requires the implementation and adjustment of therapies to limit mortality and morbidity associated with disease progression. However, this period of treatment titration remains challenging due to the need for multiple, closely spaced consultations. The difficulty in maintaining this consultation frequency, coupled with the current decline in medical demographics, largely explains the lack of treatment titration or even initiation and the existing therapeutic inertia. Concurrently, medical telemonitoring is emerging as an essential tool in heart failure management, offering significant benefits for both patients and healthcare professionals. In this context, new forms of nursing practices have emerged, such as advanced practice nursing, aimed at improving the care of patients with chronic diseases. However, only limited data are currently available regarding the functioning and impact of these consultations in France. The "Evaluation and Support Pathway for Heart Failure Patients (FIL-EAS ic)" has systematically integrated this new model of consultations provided by heart failure nurse specialists. Given their significant and growing role within the pathway, it appears necessary to thoroughly evaluate these consultations to propose improvements and maximize their effectiveness.
Interventions
Heart Failure Specialist Nurses consultations
Sponsors
Study design
Eligibility
Inclusion criteria
* Aged 18 years old or over * Patient seen in nurse-led consultations for heart failure between January 1, 2023 and December 31, 2023
Exclusion criteria
* Patient opposition to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Type of consultation | 1-year period | Medical telemonitoring, treatment titration, advanced practice nurse follow-up |
| Patient's medical history | 1-year period | Patient's clinical characteristics will be analyzed : number and type of medical histories |
| Treatments implemented | 1-year period | Type and dose of treatment initiated for heart failure will be analyzed. |
| Number of consultations | 1-year period | The number of consultations will be analyzed by type of activity (medical telemonitoring, treatment titration, advanced practice nurse follow-up). |
| Number of hospitalizations | 1-year period | The number of hospitalizations and re-hospitalizations during the 12 months of follow-up will be analyzed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Type of referral | 1-year period | The type of referral will be analyzed : in-hospital (cardiology or non-cardiology) or out-of-hospital (cardiologist, general practitioner, private nurse or Advanced Practice Registered Nurse) |
| Reason for discontinuation of titration consultation | 1-year period | The reason for the discontinuation of titration consultations will be analyzed. |
| Left ventricular ejection fraction (LVEF) | 1-year period | Echocardiography data during therapy titration will be analyzed. |
| Modification of recommended treatment doses | 1-year period | Modification of recommended treatment doses in heart failure will be analyzed in the overall cohort and according to the level of LVEF at initial management. |
| Rate of detection of iron deficiency | 1-year period | The rate of detection of iron deficiency will be analyzed according to whether or not Ferinject supplementation is used. |
Countries
France
Contacts
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer